(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-10-(1-hydroxypropyl)-6a,8a-dimethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
23-Hydroxy Budesonide is a fully characterized chemical compound used as a reference standard of API Budesonide. The standard offered is compliant with regulatory guidelines. 23-Hydroxy Budesonide is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - N/A
Related products
Budesonide EP Impurity H (Mixture of Diastereomers)
M.F.
M.W. 412.53
CAT# AR-B02178
CAS# 313474-58-7
Budesonide EP Impurity J (Mixture of Diastereomers)
M.F.
M.W. 509.44
CAT# AR-B02176
CAS# 313474-59-8
6-alpha-Hydroxy Budesonide (Mixture of Diastereomers)
M.F.
M.W. 446.55
CAT# AR-B02158
CAS# 577777-51-6
6-beta-Hydroxy Budesonide (Mixture of Diastereomers)
M.F.
M.W. 446.54
CAT# AR-B02159
CAS# 88411-77-2
Budesonide EP Impurity B (Mixture of Diastereomers)
M.F.
M.W. 402.49
CAT# AR-D01927
CAS# 1040085-98-0